Forepont Capital Partners is a Medtech and biotech focused venture capital firm which was founded in 2017, headquartered in New York with a presence in Europe. Our mission is to invest in biotech, medtech and digital-health start-ups in the US and Europe while providing scientific, technological financial and operational support. The fund has developed strong and tight partnerships with industry leaders (researchers, hospitals, academia, large pharmaceutical groups) who have vastly contributed to the performance of the existing portfolio, and that contributed to generating a proprietary deal flow.
Company Details
- Employees
- 10
- Address
- 135 E 57th St, New York,new York 10022,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.forepont.com
- Keywords
- uCat.
- HQ
- New York, New York
Forepont Capital Partners Questions
Forepont Capital Partners's website is http://www.forepont.com
Forepont Capital Partners's LinkedIn profile is https://www.linkedin.com/company/forepontgrouplp
Forepont Capital Partners has
10 employees.
View email and phone details for 10
employees at Forepont Capital Partners.
Forepont Capital Partners's industry is
Venture Capital and Private Equity Principals
Forepont Capital Partners's top competitors are
Bebtech Solutions,
Okeiro (Ex Predict4health),
Eckuity Capital,
Nouvelle Ère,
Plutus Investment Group Llp,
Jumpspace Ventures,
Neurosoft Bioelectronics,
Red River West,
Alven,
Ucat.
Forepont Capital Partners's categories are Venture Capital and Private Equity Principals
